COX6C, COX7C, ATP5I, and UQCRH mRNA levels, measured on the same microarray population and 10 additional CKD patients on stage IV–V, were significantly higher in HD and CKD IV–V compared to CKD II–III and healthy subjects. This evidence concerns the gene ATP5ME and chronic kidney disease.